Indazole scaffold: a generalist for marketed and clinical drugs

被引:33
作者
Cao, Yaquan [1 ,2 ,3 ,4 ]
Luo, Chunying [1 ,2 ,3 ,4 ]
Yang, Pu [1 ,2 ,3 ,4 ]
Li, Pan [1 ,2 ,3 ,4 ]
Wu, Chunli [1 ,2 ,3 ,4 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Key Lab Adv Drug Preparat Technol, Mil Educ, Zhengzhou 450001, Peoples R China
[3] Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[4] Zhengzhou Key Lab New Vet Drug Preparat Innovat, Zhengzhou 450001, Peoples R China
关键词
Indazole; Clinical; Drug; Disease; Pharmacology activity; PHASE-II TRIAL; TYROSINE KINASE INHIBITOR; CHEMOTHERAPY-INDUCED NAUSEA; METASTATIC BREAST-CANCER; CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL LUNG-CANCER; DUP-937; TELOXANTRONE; ANTITUMOR-ACTIVITY; MALIGNANT-MELANOMA; ANTICANCER-DRUG;
D O I
10.1007/s00044-020-02665-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
More and more attention has been paid to the structurally diverse indazole analogs in recent years which are widely present in numerous commercially available drugs. Indazole-containing derivatives are endowed with a broad range of biological properties, such as anti-inflammatory, antibacterial, anti-HIV, antiarrhythmics, antifungal and antitumor activities. This review is a guide for pharmacologists who are in search of valid preclinical/clinical drug compounds where the progress, from 1966 to the present day, of approved marketed drugs containing indazole scaffold is examined.
引用
收藏
页码:501 / 518
页数:18
相关论文
共 129 条
[51]   Axitinib: A Review in Advanced Renal Cell Carcinoma [J].
Keating, Gillian M. .
DRUGS, 2015, 75 (16) :1903-1913
[52]   Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma [J].
Keisner S.V. ;
Shah S.R. .
Drugs, 2011, 71 (4) :443-454
[53]  
Kelly RJ, 2010, RECENT RESULTS CANC, V184, P33, DOI 10.1007/978-3-642-01222-8_3
[54]  
Koc G, 2011, CAN J UROL, V18, P5991
[55]   Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles) [J].
Krapcho, AP ;
Menta, E ;
Oliva, A ;
Di Domenico, R ;
Fiocchi, L ;
Maresch, ME ;
Gallagher, CE ;
Hacker, MP ;
Beggiolin, G ;
Giuliani, FC ;
Pezzoni, G ;
Spinelli, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5429-5444
[56]   Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial [J].
Krop, Ian E. ;
Mayer, Ingrid A. ;
Ganju, Vinod ;
Dickler, Maura ;
Johnston, Stephen ;
Morales, Serafi N. ;
Yardley, Denise A. ;
Melichar, Bohuslav ;
Forero-Torres, Andres ;
Lee, Soo Chin ;
de Boer, Richard ;
Petrakova, Katarina ;
Vallentin, Susanne ;
Perez, Edith A. ;
Piccart, Martine ;
Ellis, Matthew ;
Winer, Eric ;
Gendreau, Steven ;
Derynck, Mika ;
Lackner, Mark ;
Levy, Gallia ;
Qiu, Jiaheng ;
He, Jing ;
Schmid, Peter .
LANCET ONCOLOGY, 2016, 17 (06) :811-821
[57]   Phase II study of CI-958 in patients with hormone refractory prostate carcinoma [J].
Kuebler, JP ;
Moore, T ;
Pritchard, J ;
Kraut, E .
INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) :181-184
[58]   Osmium(III) Analogues of KP1019: Electrochemical and Chemical Synthesis, Spectroscopic Characterization, X-ray Crystallography, Hydrolytic Stability, and Antiproliferative Activity [J].
Kuhn, Paul-Steffen ;
Buechel, Gabriel E. ;
Jovanovic, Katarina K. ;
Filipovic, Lana ;
Radulovic, Sinisa ;
Rapta, Peter ;
Arion, Vladimir B. .
INORGANIC CHEMISTRY, 2014, 53 (20) :11130-11139
[59]  
Kusakabe Naohisa, 2018, Hinyokika Kiyo, V64, P353, DOI 10.14989/ActaUrolJap_64_9_353
[60]   Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts [J].
Lai, Andiliy ;
Kahraman, Mehmet ;
Govek, Steven ;
Nagasawa, Johnny ;
Bonnefous, Celine ;
Julien, Jackie ;
Douglas, Karensa ;
Sensintaffar, John ;
Lu, Nhin ;
Lee, Kyoung-jin ;
Aparicio, Anna ;
Kaufman, Josh ;
Qian, Jing ;
Shao, Gang ;
Prudente, Rene ;
Moon, Michael J. ;
Joseph, James D. ;
Darimont, Beatrice ;
Brigham, Daniel ;
Grillot, Kate ;
Heyman, Richard ;
Rix, Peter J. ;
Hager, Jeffrey H. ;
Smith, Nicholas D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) :4888-4904